Tag: circulatingTumorCell

Articles

• Morphine during surgery might increase risk of metastasis

News

02/21/16

HDL from BC patients with type 2 diabetes can promote metastasis

Studies

• Cancer treatments as paradoxical catalysts of tumor awakening in the lung Cite
  Nicolas E, Kosmider B, Cukierman E, Borghaei H, Golemis EA, Borriello L. Cancer treatments as paradoxical catalysts of tumor awakening in the lung. Cancer and Metastasis Reviews. Springer Science and Business Media LLC; 2024; 10.1007/s10555-024-10196-5
• Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis Cite
  Alkhafaji S, Wolf DM, Magbanua MJM, J. van ‘t Veer L, Park JW, Esserman L, et al. Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis. npj Breast Cancer. Springer Science and Business Media LLC; 2024; 10 10.1038/s41523-024-00623-9
• Circulating tumor cells and vitamin D in primary breast cancer. Cite
  Mego M, Vlkova B, Karaba M, Minarik G, Benca J, Sedlackova T, et al. Circulating tumor cells and vitamin D in primary breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:e12558-e12558 10.1200/jco.2022.40.16_suppl.e12558
• Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis Cite
  Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, et al. Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis. npj Breast Cancer. Springer Science and Business Media LLC; 2022; 8 10.1038/s41523-022-00445-7
• The metastatic spread of breast cancer accelerates during sleep Cite
  Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. Springer Science and Business Media LLC; 2022; 10.1038/s41586-022-04875-y
• Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches Cite
  Cescon DW, Kalinsky K, Parsons HA, Smith KL, Spears PA, Thomas A, et al. Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches. Frontiers in Oncology. Frontiers Media SA; 2022; 11 10.3389/fonc.2021.667397
• Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice Cite
  Hamza B, Miller AB, Meier L, Stockslager M, Ng SR, King EM, et al. Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-25917-5
• Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells Cite
  Wang X, Liu X, Jia Z, Zhang Y, Wang S, Zhang H. Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells. Foods. MDPI AG; 2021; 10:2223 10.3390/foods10092223
• In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells Cite
  Zhu X, Suo Y, Fu Y, Zhang F, Ding N, Pang K, et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells. Light: Science & Applications. Springer Science and Business Media LLC; 2021; 10 10.1038/s41377-021-00542-5
• Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis Cite
  Pang S, Jia M, Gao J, Liu X, Guo W, Zhang H. Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis. Life Sciences. Elsevier BV; 2020; 264:118720 10.1016/j.lfs.2020.118720
• Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells Cite
  Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba BM, et al. Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells. Cell Reports. Elsevier BV; 2020; 32:108105 10.1016/j.celrep.2020.108105
• Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer Cite
  Radovich M, Jiang G, Hancock BA, Chitambar C, Nanda R, Falkson C, et al. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2020; 6:1410 10.1001/jamaoncol.2020.2295
• Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer Cite
  Moss J, Zick A, Grinshpun A, Carmon E, Maoz M, Ochana B, et al. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer. Annals of Oncology. Elsevier BV; 2020; 31:395-403 10.1016/j.annonc.2019.11.014
• Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery Cite
  Li S, Yan W, Yang X, Chen L, Fan L, Liu H, et al. Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-6158-3
• Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer Cite
  Sparano J, O’Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, et al. Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2018; 4:1700 10.1001/jamaoncol.2018.2574
• Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment Cite
  Bauer ECA, Schochter F, Widschwendter P, DeGregorio A, Andergassen U, Friedl TWP, et al. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:571-580 10.1007/s10549-018-4856-1
• Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis Cite
  Bidard F, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, et al. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 110:560-567 10.1093/jnci/djy018
• Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients Cite
  Zhang X, Hofmann S, Rack B, Harbeck N, Jeschke U, Sixou S. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients. International Journal of Molecular Sciences. MDPI AG; 2017; 18:1318 10.3390/ijms18061318
• Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer. Cite
  Ni C, Yang L. Aspirin to inhibit the formation and EMT of circulating tumor cells in patients with metastatic colorectal cancer but not breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e23024-e23024 10.1200/jco.2017.35.15_suppl.e23024
• Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells Cite
  Anjanappa M, Cardoso A, Cheng L, Mohamad S, Gunawan A, Rice S, et al. Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells. Cancer Research. American Association for Cancer Research (AACR); 2017; 77:2759-2769 10.1158/0008-5472.can-16-3308
• Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients Cite
  Aktas B, Westerwick D, Mairinger F, Kasimir-Bauer S, Kimmig R, Schmid K, et al. Abstract P1-01-09: Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients. Poster Session Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-p1-01-09
• CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer Cite
  Dai M, Zhang C, Ali A, Hong X, Tian J, Lo C, et al. CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep35383
• Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab Cite
  Pierga J, Bidard F, Autret A, Petit T, Andre F, Dalenc F, et al. Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of Oncology. Elsevier BV; 2017; 28:103-109 10.1093/annonc/mdw535
• Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy Cite
  Kasimir-Bauer S, Bittner A, König L, Reiter K, Keller T, Kimmig R, et al. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0679-3
• Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients Cite
  Zhang S, Li L, Wang T, Bian L, Hu H, Xu C, et al. Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2578-5
• The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis Cite
  Lu Y, Wang P, Wang X, Peng J, Zhu Y, Shen N. The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis. Oncotarget. Impact Journals, LLC; 2016; 7:37361-37369 10.18632/oncotarget.8156
• Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice Cite
  Donnenberg VS, Huber A, Basse P, Rubin JP, Donnenberg AD. Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice. npj Breast Cancer. Springer Science and Business Media LLC; 2016; 2 10.1038/npjbcancer.2016.4
• Abstract P2-02-02: Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer Cite
  Janni W, Schramm A, Friedl T, Schochter F, Huober J, Rack B, et al. Abstract P2-02-02: Predictors for discordance in HER2 phenotype between primary tumor and circulating tumor cells in women with metastatic breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p2-02-02
• High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation Cite
  Huang X, He D, Ming J, He Y, Zhou C, Ren H, et al. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:441-455 10.1007/s10549-016-3696-0
• Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer Cite
  Janni WJ, Rack B, Terstappen LW, Pierga J, Taran F, Fehm T, et al. Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2016; 22:2583-2593 10.1158/1078-0432.ccr-15-1603
• Circulating tumor cells in early breast cancer: A connection with vascular invasion Cite
  Maltoni R, Fici P, Amadori D, Gallerani G, Cocchi C, Zoli M, et al. Circulating tumor cells in early breast cancer: A connection with vascular invasion. Cancer Letters. Elsevier BV; 2015; 367:43-48 10.1016/j.canlet.2015.06.020
• Circulating tumor cells before and during follow-up after breast cancer surgery Cite
  VAN DALUM G, VAN DER STAM GJ, TIBBE AG, FRANKEN B, MASTBOOM WJ, VERMES I, et al. Circulating tumor cells before and during follow-up after breast cancer surgery. International Journal of Oncology. Spandidos Publications; 2014; 46:407-413 10.3892/ijo.2014.2694
• Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Cite
  Babayan A, Hannemann J, Spötter J, Müller V, Pantel K, Joosse SA. Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e75038 10.1371/journal.pone.0075038
• Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer Cite
  Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, et al. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Medicine. Wiley; 2013; 2:226-233 10.1002/cam4.70
• Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Cite
  Jain S, Cohen J, Ward M, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Annals of Oncology. Elsevier BV; 2013; 24:1491-1498 10.1093/annonc/mds654
• Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer Cite
  Bidard F, Mathiot C, Delaloge S, Brain E, Giachetti S, de Cremoux P, et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Annals of Oncology. Elsevier BV; 2010; 21:729-733 10.1093/annonc/mdp391